The Casein Peptone Market is expected to expand at a 4.2% CAGR from 2023 to 2033, from USD 395.6 million in 2023 to USD 595.7 million in 2033.
Peptone's Advantageous Qualities to Increase Product Demand in a Variety of Application Sectors
Peptone is a popular microbiological growth media. Peptone is a great natural source of peptides, proteins, and amino acids in growth media because it is a water-soluble mixture of polypeptides and amino acids that are widely used in many biological and biotechnological applications. It also acts as a nitrogen source in many complex medias. It does not coagulate when heated, is soluble in water, and is thus particularly well suited for inclusion in microbiological culture media.
Peptone has proven to be an effective supplement and an alternative to serums in the proliferation of mammalian cells and the production of biological products. Furthermore, peptone supplementation has various advantages in cell culture applications since it contains low molecular weight nutrients, peptides, and free amino acids that are appropriate for this application.
The manufacturers are aggressively investing in the development of BSE- bovine spongiform encephalopathy and GMO-free peptones and extracts, which are two of the most important safety concerns. Plants are being employed as a natural source of peptone synthesis, not only to eliminate the potential of BSE; but also to allow specific microbes to develop quickly. This is expected to have a positive impact on market development over the forecast period.
| Report Attribute | Details |
|---|---|
| Casein Peptone Market Value (2023) | USD 395.6 million |
| Casein Peptone Market Anticipated Value (2033) | USD 595.7 million |
| Casein Peptone Market Growth Rate (2023 to 2033) | 4.2% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The Casein Peptone Market was accounted for USD 380.4 million in 2022, securing a 2.8% CAGR from 2017 to 2022. Global Market Absolute Dollar Growth is USD 200.1 million.
The casein peptone market has been registering high demand from the expanding pharmaceutical industry. Casein peptone plays a crucial role in production of culture media for laboratory tests. As the diagnostic and pharmaceutical industry is expanding steadily, the demand for acid casein peptone, calcium casein peptone, and others is skyrocketing. Furthermore, the rise in vaccine production process is creating growth opportunities for the market.
According to the World Health Organization (WHO), 172 countries and multiple candidate vaccines are engaged in discussions to potentially participate in COVAX while countries such as China, Russia, India, Japan, and others are starting with their vaccine production processes.
Casein peptone being an integral part of producing vaccines, is gaining considerable traction. As casein peptone is required in the manufacturing of enzymes, toxins, and other biological products, the growth in biochemical industry is catering to the rising demand for casein peptone.
| Historical CAGR (2017 to 2022) | 2.8% |
|---|---|
| Forecast CAGR (2023 to 2033) | 4.2% |
Short-Term (2023 to 2026): The market's short-term growth prospects are promising. The increasing need for casein peptone in diagnostic media production is propelling the casein peptone market forward.
Medium-Term (2026 to 2029): The market may climb somewhat over this period. In response to rising biomass output, the use of casein peptone is expected to skyrocket in the future years.
Long-Term (2029 to 2033): According to FMI's forecast, the market is going to enter a boom phase over this time period. Peptone is in high demand to help microorganisms grow and offer nutrients for numerous purposes in sectors such as food and cosmetics in the upcoming years.
As per the FMI analysts, a valuation of USD 595.7 million by 2033 end is estimated for the market.
| Year | Valuation |
|---|---|
| 2016 | USD 296.61 million |
| 2021 | USD 364.35 million |
| 2022 | USD 380.4 million |
| 2023 | USD 395.6 million |
| 2033 | USD 595.7 million |
As casein peptone is costly, it is yet to be widely adopted by small to medium-scale pharmaceutical and biochemical companies and other institutes. Furthermore, casein peptone has disadvantages such as the presence of casein peptone interferes with the isolation of various products including specific carbohydrates, enzymes, toxins, and others.
The variation between the peptones even of the same brand often comes in the ways of ensuring production efficiency. These factors could hamper the growth of the market to an extent.
The COVID-19 pandemic has had a negative impact on the market as well, causing the decline in demand in the earlier part of 2020, which is going to last till year 2021.
| Country | The United States |
|---|---|
| CAGR (2017 to 2022) | 4.0% |
| Valuation (2023 to 2033) | USD 80.4 million |
| Country | The United Kingdom |
|---|---|
| CAGR (2017 to 2022) | 3.3% |
| Valuation (2023 to 2033) | USD 12.7 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 2.8% |
| Valuation (2023 to 2033) | USD 63.1 million |
| Country | Europe |
|---|---|
| CAGR (2017 to 2022) | 3.8% |
| Valuation (2023 to 2033) | USD 38.3 million |
| Country | India |
|---|---|
| CAGR (2017 to 2022) | 2.8% |
| Valuation (2023 to 2033) | USD 31.2 million |
East Asia is presently leading in the global market and is anticipated to remain dominant through the forecast period. The increasing requirement for biomass production, coupled with increasing research & development activities in countries such as China, Japan, South Korea, and others is projected to drive East Asia market in the coming years.
East Asia market is expected to gain significant impetus from the increasing demand from its well-developed cosmetics industry. According to FMI, China to emerge as the dominant economy in the coming years. Japan remains lucrative throughout the forecast period.
Europe is the second leading in the casein peptone market and is set to grow steadily in the coming years. The presence of a well-established pharmaceutical industry is bolstering growth in Europe. With the rising demand for casein peptone in diagnostic media production, Europe market is set to exhibit exponential growth in the coming years.
Several vaccine production initiatives and trials are catering to the growth in Europe. For instance, Britain has launched the West’s first mass coronavirus vaccination in December; 2020.
EU-4 (Germany, France, Italy, Spain) are expected to lead in Europe in the coming years.
The surging research & development activities conducted across the biotech & pharmaceutical industry are driving North America market.
North America also is the notable importer of casein peptone across the globe. The highly advanced infrastructure for biochemical research, enzyme production, diagnostic media production, and others is forecasted to grow North America market.
The United States is expected to remain dominant in North America peptone powder market soon.
Presently, diagnostic media production is leading in the global market in terms of application. Diagnostic media is a special mixture of specific nutrient substances on which microorganisms are grown in order to determine the species to which they belong. Diagnostic media production includes the production of basic simple reagents for health laboratory services.
Casein peptone being highly efficient in increasing the micro-organisms in the production process is widely required in the production of various diagnostic media such as selective media, transport media, storage media, basal media, enriched media, indicator media, and others.
The growing usage of microbiological cultures is anticipated to boost the growth of the market in forthcoming years.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The casein peptone market is set to exhibit steady growth during the forecast period. In order to capitalize on the market potential, the casein peptone manufacturers are focusing on launching a wide range of casein peptone products including calcium casein peptone, acid casein peptone, and others.
| Attribute | Details |
|---|---|
| Market Size Value In 2023 | USD 395.6 million |
| Market Size Value in End of Forecast (2033) | USD 595.7 million |
| Market Analysis | USD million for Value |
| Key Region Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific Excluding Japan; The Middle East and Africa; Japan |
| Key Segments | By Application, By Region |
| Key Companies Profiled | Apollo Scientific Ltd; Amyl Media Pty Ltd; Neogen Corporation; Merck KGaA; MP Biomedicals LLC; Carl Roth GmbH & Co. KG; Azelis Americas, LLC; Thermo Fisher Scientific, Inc.; Biolife Italiana S.r.l. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 395.6 million in 2023.
Apollo Scientific Ltd, Amyl Media Pty Ltd, and Neogen Corporation are key casein peptone market players.
Recombinant casein peptone is likely to remain preferred through 2033.
Players opt for partnerships and collaborations.
India, Japan, and China dominate the Asian market.
| Expected Market value in 2023 | USD 1.6 Billion |
|---|---|
| Projected Market Value in 2033 | USD 2.5 Billion |
| CAGR (2023 to 2033) | 4.6% |
| Market Size in (2023) | USD 140 million |
|---|---|
| Market Size in (2033) | USD 209 million |
| Market CAGR (2023 to 2033) | 4% |
Explore Functional Food Ingredients Insights
View Reports
Casein Peptone Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
